Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
Stingl G, Brŏcker EB, Mertelsmann R, Wolff K, Schreiber S, Kămpgen E, Schneeberger A, Dummer W, Brennscheid U, Veelken H, Birnstiel ML, Zatloukal K, Schmidt W, Maass G, Wagner E, Baschle M, Giese M, Kempe ER, Weber HA, Voigt T. Stingl G, et al. Among authors: brocker eb. Hum Gene Ther. 1996 Mar 1;7(4):551-63. doi: 10.1089/hum.1996.7.4-551. Hum Gene Ther. 1996. PMID: 8800750 Clinical Trial. No abstract available.
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
Stingl G, Bröcker EB, Mertelsmann R, Wolff K, Schreiber S, Kämpgen E, Schneeberger A, Trcka J, Brennscheidt U, Veelken H, Birnstiel ML, Zatloukal K, Maass G, Wagner E, Buschle M, Kempe ER, Weber HA, Voigt T. Stingl G, et al. Among authors: brocker eb. J Mol Med (Berl). 1997 Apr;75(4):297-9. doi: 10.1007/s001090050115. J Mol Med (Berl). 1997. PMID: 9151216 Clinical Trial. No abstract available.
Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study.
Schreiber S, Kämpgen E, Wagner E, Pirkhammer D, Trcka J, Korschan H, Lindemann A, Dorffner R, Kittler H, Kasteliz F, Küpcü Z, Sinski A, Zatloukal K, Buschle M, Schmidt W, Birnstiel M, Kempe RE, Voigt T, Weber HA, Pehamberger H, Mertelsmann R, Bröcker EB, Wolff K, Stingl G. Schreiber S, et al. Among authors: brocker eb. Hum Gene Ther. 1999 Apr 10;10(6):983-93. doi: 10.1089/10430349950018382. Hum Gene Ther. 1999. PMID: 10223732 Clinical Trial.
Classical chemotherapy for metastatic melanoma.
Becker JC, Kämpgen E, Bröcker E. Becker JC, et al. Clin Exp Dermatol. 2000 Sep;25(6):503-8. doi: 10.1046/j.1365-2230.2000.00690.x. Clin Exp Dermatol. 2000. PMID: 11044186 Review.
[Cell therapy with dendritic cells].
Kämpgen E, Becker J, Bröcker EB. Kämpgen E, et al. Among authors: brocker eb. Internist (Berl). 2001 Oct;42(10):1314-20. doi: 10.1007/s001080170053. Internist (Berl). 2001. PMID: 11688150 Review. German. No abstract available.
543 results